Article Data

  • Views 471
  • Dowloads 112

Case Reports

Open Access

An unusual ovarian neoplasm diagnosed in a patient with rupture of unicornuate uterus during pregnancy: a case report

  • T.Y. Liu1
  • Y.X. Zhu2
  • P.Q. Ke1
  • M. He1
  • Y.C. Liang1
  • S.Z. Yao1,*,

1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Ultrasonic Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

DOI: 10.12892/ejgo3243.2016 Vol.37,Issue 5,October 2016 pp.732-735

Published: 10 October 2016

*Corresponding Author(s): S.Z. Yao E-mail: yszlfy@163.com

Abstract

Unicornuate uterus is a rare disease characterized with reduced fertility, and ovarian tumor diagnosed during pregnancy is uncommon as well. These two diseases have been reported separately. However, patient suffering from both diseases has never been reported before. The authors herein report a case of a 32-year-old Chinese woman presenting with a unicornuate uterus with no horn, who suffered from acute abdominal pain and intra-abdominal hemorrhage at 26 weeks gestation. Incidentally, a borderline ovarian tumor (BOT) and rupture of uterus were found during an urgent exploratory laparotomy. During the follow-up, ovarian tumor recurred in the first year after the operation. The authors suggest that BOT with micropapillary patterns should be paid much more attention to, other than only assessing the histological type. Furthermore, they also suggest that a slightly increased in serum CA-125 value should not be ignored.

Keywords

Urogenital abnormalities; Uterine rupture; Pregnancy; Ovarian neoplasms; Recurrence.

Cite and Share

T.Y. Liu,Y.X. Zhu,P.Q. Ke,M. He,Y.C. Liang,S.Z. Yao. An unusual ovarian neoplasm diagnosed in a patient with rupture of unicornuate uterus during pregnancy: a case report. European Journal of Gynaecological Oncology. 2016. 37(5);732-735.

References

[1] Jayaprakasan K., Chan Y.Y., Sur S, Deb S., Clewes J.S., Raine-Fenning N.J.: “Prevalence of uterine anomalies and their impact on early pregnancy in women conceiving after assisted reproduction treatment”. Ultrasound Obstet. Gynecol., 2011, 37, 727.

[2] Akar M.E., Bayar D., Yildiz S., Ozel M., Yilmaz Z.: “Reproductive outcome of women with unicornuate uterus”. Aust. N. Z. J. Obstet. Gynaecol., 2005, 45, 148.

[3] Grimm D., Woelber L., Trillsch F., Keller-v Amsberg G., Mahner S.: “Clinical management of epithelial ovarian cancer during pregnancy”. Eur. J. Cancer, 2014, 50, 963.

[4] Abascal-Saiz A., Sotillo-Mallo L., de Santiago J., Zapardiel I.: “Management of borderline ovarian tumours: a comprehensive review of the literature”. Ecancermedicalscience, 2014, 8, 403.

[5] Reichman D., Laufer M.R., Robinson B.K.: “Pregnancy outcomes in unicornuate uteri: a review”. Fertil. Steril., 2009, 91, 1886.

[6] Fauvet R., Brzakowski M., Morice P., Resch B., Marret H., Graesslin O., Darai E.: “Borderline ovarian tumors diagnosed during pregnancy exhibit a high incidence of aggressive features: results of a French multicenter study”. Ann. Oncol., 2012, 23, 1481.

[7] Morice P., Camatte S., El H.J., Pautier P., Duvillard P., Castaigne D.: “Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors”. Fertil. Steril., 2001, 75, 92.

[8] Vasconcelos I., de Sousa M.M.: “Conservative surgery in ovarian borderline tumours: A meta-analysis with emphasis on recurrence risk”. Eur. J. Cancer, 2015, 51, 620.

[9] Palomba S., Zupi E., Russo T., Falbo A., Del N.S., Manguso F., et al.: “Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study”. Hum. Reprod., 2007, 22, 578.

[10] Yinon Y., Beiner M.E., Gotlieb W.H., Korach Y., Perri T., Ben- Baruch G.: “Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors”. Fertil. Steril., 2007, 88, 479.

[11] Song T., Hun C.C., Lee Y.Y., Kim T.J., Lee J.W., Bae D.S., Kim B.G.: “Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours”.Hum. Reprod., 2011, 26, 2008. [12] Shih K.K., Zhou Q., Huh J., Morgan J.C., Iasonos A., Aghajanian C., et al.: “Risk factors for recurrence of ovarian borderline tumors”. Gynecol. Oncol., 2011, 120, 480.

[13] Bell D.A., Longacre T.A., Prat J., Kohn E.C., Soslow R.A., Ellenson L.H., et al.: “Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives”. Hum. Pathol., 2004, 35, 934.

[14] May T., Virtanen C., Sharma M., Milea A., Begley H., Rosen B., et al.: “Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary”. Gynecol. Oncol., 2010, 117, 9.

[15] Morice P., Uzan C., Fauvet R., Gouy S., Duvillard P., Darai E.: “Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence”. Lancet Oncol., 2012, 132, 23.

[16] Faluyi O., Mackean M., Gourley C., Bryant A., Dickinson H.O.: “Interventions for the treatment of borderline ovarian tumours”. Cochrane Database Syst Rev., 2010, 9, CD007696.

[17] Leary A., Petrella M.C., Pautier P., Duvillard P., Uzan C., Tazi Y., et al.: “Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants”. Gynecol. Oncol., 2014, 132, 23.

[18] Vasconcelos I., Olschewski J., Braicu I., Sehouli J.: “A meta-analysis on the impact of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors with invasive implants”. Oncologist, 2015, 20, 151.

[19] Marret H., Lhomme C., Lecuru F., Canis M., Leveque J., Golfier F., Morice P.: “Guidelines for the management of ovarian cancer during pregnancy”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2010, 149, 18.

[20] Anastasi E., Porpora M.G., Pecorella I., Bernardo S., Frati L., Benedetti P.P., Manganaro L.: “May increased CA125 in borderline ovarian tumor be indicative of a poor prognosis? A case report”. Tumour Biol., 2014, 35, 6969.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top